litlas
Log inCreate account

Johan Bussink

Active 2000–2025

101
Papers
18,428
Citations
69
h-index
97
i10-index

Citations

Citations per year for Johan Bussink1986: 1 citations1989: 1 citations1998: 1 citations2000: 4 citations2001: 4 citations2002: 10 citations2003: 20 citations2004: 29 citations2005: 39 citations2006: 51 citations2007: 64 citations2008: 77 citations2009: 54 citations2010: 95 citations2011: 103 citations2012: 119 citations2013: 152 citations2014: 167 citations2015: 198 citations2016: 253 citations2017: 353 citations2018: 425 citations2019: 1,045 citations2020: 1,190 citations2021: 1,187 citations2022: 770 citations2023: 512 citations2024: 710 citations2025: 373 citations2026: 47 citations1987–1988: no citations, so these years are not shown1990–1997: no citations, so these years are not shown1999: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorChina: 2,054 citing papers, 21.2% of this breakdownUnited States: 1,854 citing papers, 19.2% of this breakdownNetherlands: 561 citing papers, 5.8% of this breakdownUnited Kingdom: 531 citing papers, 5.5% of this breakdownGermany: 504 citing papers, 5.2% of this breakdownItaly: 429 citing papers, 4.4% of this breakdownCanada: 401 citing papers, 4.1% of this breakdownFrance: 296 citing papers, 3.1% of this breakdownSouth Korea: 221 citing papers, 2.3% of this breakdownSwitzerland: 192 citing papers, 2% of this breakdownIndia: 180 citing papers, 1.9% of this breakdownAustralia: 171 citing papers, 1.8% of this breakdown
0%21.2%Other 23.5%

Institutions

Fields

  • Medicine67.4%
  • Biochemistry, Genetics and Molecular Biology20.3%
  • Computer Science3.6%
  • Engineering2.8%
  • Physics and Astronomy1.8%
  • Immunology and Microbiology1.3%
  • Other2.8%

Topics

  • Radiomics and Machine Learning in Medical Imaging16.8%
  • Lung Cancer Diagnosis and Treatment4.7%
  • AI in cancer detection4.2%
  • Cancer, Hypoxia, and Metabolism4.2%
  • Advanced X-ray and CT Imaging2.9%
  • MRI in cancer diagnosis2.7%
  • Other64.5%

Coauthors

All papers

Open in search
  1. Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach

    Authors: Hugo J.W.L. Aerts, Emmanuel Rios Velazquez, Ralph T. H. Leijenaar, Chintan Parmar, Patrick Großmann, Sara Carvalho, Johan Bussink, René Monshouwer, Benjamin Haibe‐Kains, D. Rietveld, Frank Hoebers, Michelle M. Rietbergen, C. René Leemans, André Dekker, John Quackenbush, Robert J. Gillies, Philippe Lambin - Nature Communications 2014 cited by 5,145

  2. Deep learning for lung cancer prognostication: A retrospective multi-cohort radiomics study

    Authors: Ahmed Hosny, Chintan Parmar, Thibaud Coroller, Patrick Großmann, Roman Zeleznik, Avnish Kumar, Johan Bussink, Robert J. Gillies, Raymond H. Mak, Hugo J.W.L. Aerts - PLoS Medicine 2018 cited by 586

  3. Machine Learning methods for Quantitative Radiomic Biomarkers

    Authors: Chintan Parmar, Patrick Großmann, Johan Bussink, Philippe Lambin, Hugo J.W.L. Aerts - Scientific Reports 2015 cited by 1,015

  4. The unfolded protein response protects human tumor cells during hypoxia through regulation of the autophagy genes MAP1LC3B and ATG5

    Authors: Kasper M.A. Rouschop, Twan van den Beucken, Ludwig J. Dubois, Hanneke E.C. Niessen, Johan Bussink, Kim G.M. Savelkouls, Tom G. Keulers, Hilda Mujčić, Willy Landuyt, Jan Willem Voncken, Philippe Lambin, Albert J. van der Kogel, Marianne Koritzinsky, Bradly G. Wouters - Journal of Clinical Investigation 2009 cited by 802

  5. Targeting Oxidative Phosphorylation to Increase the Efficacy of Radio- and Immune-Combination Therapy

    Authors: Daan F. Boreel, Paul N. Span, Sandra Heskamp, Gosse J. Adema, Johan Bussink - Clinical Cancer Research 2021 cited by 114

  6. Machine learning algorithms for outcome prediction in (chemo)radiotherapy: An empirical comparison of classifiers

    Authors: Timo M. Deist, Frank J. W. M. Dankers, Gilmer Valdés, Robin Wijsman, I‐Chow Hsu, Cary Oberije, Tim Lustberg, Johan van Soest, Frank Hoebers, Arthur Jochems, Issam El Naqa, Leonard Wee, Olivier Morin, David R. Raleigh, Wouter Bots, Johannes H.A.M. Kaanders, J. Belderbos, Margriet Kwint, Timothy D. Solberg, René Monshouwer, Johan Bussink, André Dekker, Philippe Lambin - Medical Physics 2018 cited by 302

  7. Radiotherapy and cGAS/STING signaling: Impact on MDSCs in the tumor microenvironment

    Authors: Vera M. Kho, Vera Mekers, Paul N. Span, Johan Bussink, Gosse J. Adema - Cellular Immunology 2021 cited by 76

  8. Combining Targeted Radionuclide Therapy and Immune Checkpoint Inhibition for Cancer Treatment

    Authors: Simone C. Kleinendorst, Egbert Oosterwijk, Johan Bussink, Harm Westdorp, Mark Konijnenberg, Sandra Heskamp - Clinical Cancer Research 2022 cited by 64

  9. Targeting Hypoxia, HIF-1, and Tumor Glucose Metabolism to Improve Radiotherapy Efficacy

    Authors: Tineke W.H. Meijer, Johannes H.A.M. Kaanders, Paul N. Span, Johan Bussink - Clinical Cancer Research 2012 cited by 426

  10. Distributed learning on 20 000+ lung cancer patients – The Personal Health Train

    Authors: Timo M. Deist, Frank J. W. M. Dankers, Priyanka Ojha, M. Scott Marshall, Tomas Janssen, Corinne Faivre‐Finn, Carlotta Masciocchi, Vincenzo Valentini, Jiazhou Wang, Jiayan Chen, Zhen Zhang, Emiliano Spezi, Mick Button, Joost J. Nuyttens, René M. Vernhout, Johan van Soest, Arthur Jochems, René Monshouwer, Johan Bussink, Gareth Price, Philippe Lambin, André Dekker - Radiotherapy and Oncology 2020 cited by 163

  11. Exploratory Study to Identify Radiomics Classifiers for Lung Cancer Histology

    Authors: Weimiao Wu, Chintan Parmar, Patrick Großmann, John Quackenbush, Philippe Lambin, Johan Bussink, Raymond H. Mak, Hugo J.W.L. Aerts - Frontiers in Oncology 2016 cited by 372

  12. Radiomic feature clusters and Prognostic Signatures specific for Lung and Head & Neck cancer

    Authors: Chintan Parmar, Ralph T. H. Leijenaar, Patrick Großmann, Emmanuel Rios Velazquez, Johan Bussink, D. Rietveld, Michelle M. Rietbergen, Benjamin Haibe‐Kains, Philippe Lambin, Hugo J.W.L. Aerts - Scientific Reports 2015 cited by 437

  13. PERK/eIF2α signaling protects therapy resistant hypoxic cells through induction of glutathione synthesis and protection against ROS

    Authors: Kasper M.A. Rouschop, Ludwig J. Dubois, Tom G. Keulers, Twan van den Beucken, Philippe Lambin, Johan Bussink, Albert J. van der Kogel, Marianne Koritzinsky, Bradly G. Wouters - National Academy of Sciences, Proceedings of the National Academy of Sciences 2013 cited by 209

  14. Biology of Hypoxia

    Authors: Paul N. Span, Johan Bussink - Seminars in Nuclear Medicine 2015 cited by 165

  15. The mechanical microenvironment in cancer: How physics affects tumours

    Authors: Anika Nagelkerke, Johan Bussink, Alan E. Rowan, Paul N. Span - Seminars in Cancer Biology 2015 cited by 153

  16. Correction: Corrigendum: Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach

    Authors: Hugo J.W.L. Aerts, Emmanuel Rios Velazquez, Ralph T. H. Leijenaar, Chintan Parmar, Patrick Großmann, Sara Carvalho, Johan Bussink, René Monshouwer, Benjamin Haibe‐Kains, D. Rietveld, Frank Hoebers, Michelle M. Rietbergen, C. René Leemans, André Dekker, John Quackenbush, Robert J. Gillies, Philippe Lambin - Nature Communications 2014 cited by 318

  17. Hypoxia stimulates migration of breast cancer cells via the PERK/ATF4/LAMP3-arm of the unfolded protein response

    Authors: Anika Nagelkerke, Johan Bussink, Hilda Mujčić, Bradly G. Wouters, Steffi Lehmann, Fred C.G.J. Sweep, Paul N. Span - Breast Cancer Research 2013 cited by 226

  18. Metabolic markers in relation to hypoxia; staining patterns and colocalization of pimonidazole, HIF-1α, CAIX, LDH-5, GLUT-1, MCT1 and MCT4

    Authors: Saskia E. Rademakers, Jasper Lok, Albert J. van der Kogel, Johan Bussink, Johannes H.A.M. Kaanders - BMC Cancer 2011 cited by 212

  19. Longitudinal radiomics of cone-beam CT images from non-small cell lung cancer patients: Evaluation of the added prognostic value for overall survival and locoregional recurrence

    Authors: Janita E. van Timmeren, Wouter van Elmpt, Ralph T. H. Leijenaar, Bart Reymen, René Monshouwer, Johan Bussink, Leen Paelinck, E. Bogaert, Carlos De Wagter, Elamin Elhaseen, Yolande Lievens, Olfred Hansen, Carsten Brink, Philippe Lambin - Radiotherapy and Oncology 2019 cited by 83

  20. Tamoxifen induces radioresistance through NRF2-mediated metabolic reprogramming in breast cancer

    Authors: F. V. Reinema, Fred C.G.J. Sweep, Gosse J. Adema, Wenny J.M. Peeters, John W.M. Martens, Johan Bussink, P. N. Span - Cancer & Metabolism 2023 cited by 53

  21. Cancer-associated fibroblasts, tumor and radiotherapy: interactions in the tumor micro-environment

    Authors: Kris Raaijmakers, Gosse J. Adema, Johan Bussink, Marleen Ansems - Journal of Experimental & Clinical Cancer Research 2024 cited by 54

  22. Secretion of pro‐angiogenic extracellular vesicles during hypoxia is dependent on the autophagy‐related protein GABARAPL1

    Authors: Tom G. Keulers, Sten F.W.M. Libregts, Joël E.J. Beaumont, Kim G.M. Savelkouls, Johan Bussink, Hans Duimel, Ludwig J. Dubois, Marijke I. Zonneveld, Carmen López‐Iglesias, Karel Bezstarosti, Jeroen Demmers, Marc Vooijs, Marca H. M. Wauben, Kasper M.A. Rouschop - Journal of Extracellular Vesicles 2021 cited by 35

  23. Survival prediction of non-small cell lung cancer patients using radiomics analyses of cone-beam CT images

    Authors: Janita E. van Timmeren, Ralph T. H. Leijenaar, Wouter van Elmpt, Bart Reymen, Cary Oberije, René Monshouwer, Johan Bussink, Carsten Brink, Olfred Hansen, Philippe Lambin - Radiotherapy and Oncology 2017 cited by 182

  24. Interferon-Stimulated Genes Are Involved in Cross-resistance to Radiotherapy in Tamoxifen-Resistant Breast Cancer

    Authors: Annemarie E.M. Post, Marcel Smid, Anika Nagelkerke, John W.M. Martens, Johan Bussink, Fred C.G.J. Sweep, Paul N. Span - Clinical Cancer Research 2018 cited by 102